Oculus Innovative Sciences launches Microcyn
This article was originally published in The Gray Sheet
Executive Summary
Firm debuts the skin and wound cleaner in both professional and over-the-counter versions Aug. 18. The former product is indicated for debridement of wounds like stage I-IV pressure ulcers, diabetic foot ulcers, post-surgical wounds and first- and second-degree burns, while the OTC version is indicated for use in cleansing dirt and debris from lacerations, skin abrasions, minor burns and minor skin irritations. The product, which received 510(k) clearance in May, is effective against a broad spectrum of gram-positive, gram-negative and yeast species, according to the Petaluma, Calif., company. Oculus also will introduce a Microcyn hydrogel OTC formulation in October, followed by a full launch to medical professionals in 2010, the company says